MAIA — Maia Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Maia Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.6 | -15.8 | -19.8 | -23.3 | -22.4 |
| Non-Cash Items | 7.33 | 3.32 | 3.62 | 8.79 | 2.05 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.13 | 0.793 | 3.09 | -1.24 | 1.5 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -4.12 | -11.7 | -13.1 | -15.7 | -18.8 |
| Financing Cash Flow Items | 0.322 | -2.41 | -2.15 | -0.795 | -0.617 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14 | 12 | 9.27 | 18.2 | 17.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.91 | 0.377 | -3.8 | 2.45 | -0.943 |